Laurel Lagenaur, PhD

Laurel Lagenaur received her doctorate in Microbiology and Immunology from Stanford University, and completed a post-doctoral fellowship at the University of California, San Francisco, where she studied viral comorbidities of HIV. Dr. Lagenaur then joined a small biotech company, Osel, where she led development of a recombinant Lactobacillus technology platform as the Director of Research.  She has been the principal investigator on numerous research grants, including Osel’s first SBIR grant to develop MucoCept-HIV as a novel recombinant live biotherapeutic to prevent HIV transmission in women. Dr. Lagenaur is a molecular biologist with extensive experience in virology and bacteriology and was a clinical microbiologist in both the human and veterinary fields. 

Share and Enjoy